一项日本临床肿瘤学组关于非小细胞肺癌立体定向体部放射治疗的试验。
A Japan clinical oncology group trial for stereotactic body radiation therapy of non-small cell lung cancer.
作者信息
Hiraoka Masahiro, Ishikura Satoshi
机构信息
Department of Radiation Oncology and Image-Applied Therapy, Kyoto University Graduate School of Medicine, Shogoin Kawaharacho, Sakyo-ku, Kyoto, Japan.
出版信息
J Thorac Oncol. 2007 Jul;2(7 Suppl 3):S115-7. doi: 10.1097/JTO.0b013e318074de1b.
Stereotactic body radiation therapy (SBRT) is a new treatment modality. To confirm the safety and efficacy, the Radiation Therapy Study Group of the Japan Clinical Oncology Group (JCOG) has started a phase II study of SBRT for stage IA non-small cell lung cancer (JCOG 0403). This study is ongoing with a strict quality control and quality assurance program, and the results will indicate whether a future phase III trial comparing SBRT with surgery is warranted. In addition, international collaboration will be critical to establish the role of SBRT in the treatment of lung cancer.
立体定向体部放射治疗（SBRT）是一种新的治疗方式。为证实其安全性和有效性，日本临床肿瘤学会（JCOG）放射治疗研究组已启动一项针对IA期非小细胞肺癌的SBRT II期研究（JCOG 0403）。该研究正在严格的质量控制和质量保证计划下进行，其结果将表明是否有必要开展未来将SBRT与手术进行比较的III期试验。此外，国际合作对于确立SBRT在肺癌治疗中的作用至关重要。
Zotero 插件